pancreatic cancer metastatic
Showing 1 - 15 of 15
RWE on mPDAC Long-term Survival After Treatment With Liposomal
Recruiting
- Pancreatic Cancer Metastatic
-
Munich, GermanyKlinikum der Universität München, - Anstalt des öffentlichen Rec
Nov 24, 2023
Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine
Not yet recruiting
- Pancreatic Cancer Metastatic
- Pancreatic Adenocarcinoma Metastatic
- Botensilimab
- +3 more
-
Scottsdale, ArizonaClinical Trials Nurse Navigator
Oct 3, 2023
Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))
Not yet recruiting
- Pancreatic Cancer Metastatic
- C3 (Metformin, Simvastatin, and Digoxin)
- (no location specified)
Sep 1, 2023
Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- +12 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 30, 2022
Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic Trial in Baltimore (INCMGA00012 (PD-1 antibody))
Recruiting
- Pancreatic Cancer Non-resectable
- Pancreatic Cancer Metastatic
- INCMGA00012 (PD-1 antibody)
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Aug 16, 2022
Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Baltimore (Neoantigen Vaccine with Poly-ICLC adjuvant,
Not yet recruiting
- Pancreatic Cancer Metastatic
- Colorectal Cancer Metastatic
- Neoantigen Vaccine with Poly-ICLC adjuvant
- Retifanlimab
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Aug 5, 2022
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV, Pancreatic Cancer Non-resectable Trial in Oxford (Focused
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +3 more
- Focused Ultrasound
- +2 more
-
Oxford, United KingdomOxford University Hospitals NHS Trust
Feb 22, 2022
Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV Trial (SBP-101, Nab-paclitaxel,
Not yet recruiting
- Pancreatic Cancer Metastatic
- +2 more
- SBP-101
- +3 more
- (no location specified)
Feb 21, 2022
Pancreatic Cancer Non-resectable, Chemo-induced Nausea and Vomiting, Pancreatic Cancer Metastatic Trial in Austria, Germany
Recruiting
- Pancreatic Cancer Non-resectable
- +2 more
- Dronabinol in Oral Dosage Form
- Placebo in Oral Dosage Form
-
Wels, Oberösterreich, Austria
- +10 more
Jan 18, 2022
Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic Trial (Irinotecan Liposome Injection, Fluorouracil, Leucovorin)
Not yet recruiting
- Pancreatic Cancer Non-resectable
- Pancreatic Cancer Metastatic
- Irinotecan Liposome Injection
- +5 more
- (no location specified)
Sep 16, 2021
Colorectal Cancer Metastatic, Pancreatic Cancer Metastatic Trial in Heidelberg (Nivolumab plus Ipilimumab plus Maraviroc)
Active, not recruiting
- Colorectal Cancer Metastatic
- Pancreatic Cancer Metastatic
- Nivolumab plus Ipilimumab plus Maraviroc
-
Heidelberg, GermanyUniversity of Heidelberg / NCT
Jan 20, 2021
Pancreatic Cancer Metastatic Trial in Gainesville (Dasatinib, mFOLFOX6)
Completed
- Pancreatic Cancer Metastatic
-
Gainesville, FloridaUF Health Cancer Center
Dec 3, 2020
Pancreatic Cancer Stage IV, Pancreatic Cancer Metastatic Trial (Camrelizumab, Paclitaxel(Albumin Bound) and Gemcitabine,
Not yet recruiting
- Pancreatic Cancer Stage IV
- Pancreatic Cancer Metastatic
- Camrelizumab
- +2 more
- (no location specified)
Dec 15, 2020
Carcinoma, Hepatocellular, Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Shanghai (CAR-T cell)
Unknown status
- Carcinoma, Hepatocellular
- +2 more
- CAR-T cell
-
Shanghai, Shanghai, ChinaShanghai Tumor Hospital
Nov 7, 2016